| |
|
|
|
|
|
|
|||
|
Blood, 15 August 2005, Vol. 106, No. 4, pp. 1203-1206. Prepublished online as a Blood First Edition Paper on April 19, 2005; DOI 10.1182/blood-2005-03-0950.
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Development of hemophagocytic lymphohistiocytosis in triplets infected with HHV-8From the Division of Pediatric Hematology, Oncology, Blood, and Marrow Transplant, Medical College of Wisconsin, Children's Hospital of Wisconsin, Milwaukee, WI; the Division of Pediatric Hematology, Oncology, Blood, and Marrow Transplant, University of Iowa Hospitals and Clinics, Iowa City, IA; and the Division of Pediatric Infectious Disease, University of Iowa Hospitals and Clinics, Iowa City, IA.
Hemophagocytic lymphohistiocytosis (HLH) is a rare disorder of immune dysregulation, characterized by end-organ damage from lymphocytic infiltration and macrophage activation. All known mutations associated with the HLH occur in genes critical in the perforin-granzyme pathway. Herein, we report HLH occurring in 2 female triplet infants who also had associated human herpesvirus type 8 (HHV-8) infections. The subjects had identical novel compound-heterozygous mutations in the Perforin alleles, resulting in undetectable perforin expression and NK-cell cytotoxicity. Both infants also had evidence of infection with HHV-8. These reports are, to our knowledge, the first cases of HLH in triplets and the first reported cases of HHV-8 infection associated with HLH in nonrenal transplant and nonHIV-infected subjects.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2005 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||